Minwei Ye

1.5k total citations
12 papers, 216 citations indexed

About

Minwei Ye is a scholar working on Oncology, Genetics and Organic Chemistry. According to data from OpenAlex, Minwei Ye has authored 12 papers receiving a total of 216 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 5 papers in Genetics and 3 papers in Organic Chemistry. Recurrent topics in Minwei Ye's work include Cytokine Signaling Pathways and Interactions (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Adenosine and Purinergic Signaling (3 papers). Minwei Ye is often cited by papers focused on Cytokine Signaling Pathways and Interactions (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Adenosine and Purinergic Signaling (3 papers). Minwei Ye collaborates with scholars based in United States and United Kingdom. Minwei Ye's co-authors include Geraldine Bebernitz, Stephanos Ioannidis, Michael Zinda, Dennis Huszar, Audrey M. Davies, Jiaquan Wu, Joseph M. Gozgit, Marat Alimzhanov, Julie Parmentier and Nancy Su and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cancer Research.

In The Last Decade

Minwei Ye

11 papers receiving 214 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Minwei Ye United States	7	97	89	69	53	37	12	216
David J. Calderwood United States	9	116 1.2×	180 2.0×	52 0.8×	133 2.5×	72 1.9×	12	381
Patrícia Maciejewski United States	4	43 0.4×	116 1.3×	79 1.1×	43 0.8×	75 2.0×	9	282
Kirsten Bell United States	7	73 0.8×	93 1.0×	57 0.8×	63 1.2×	26 0.7×	13	214
Lynsey Fazal United Kingdom	8	96 1.0×	216 2.4×	24 0.3×	66 1.2×	22 0.6×	16	330
Klemens Hoegenauer Switzerland	8	39 0.4×	148 1.7×	68 1.0×	71 1.3×	107 2.9×	9	291
Harish Nagaraj Singapore	7	134 1.4×	190 2.1×	113 1.6×	103 1.9×	26 0.7×	8	365
Pawan Bir Kohli China	3	113 1.2×	86 1.0×	62 0.9×	13 0.2×	55 1.5×	3	198
Audrey M. Davies United States	8	99 1.0×	116 1.3×	60 0.9×	74 1.4×	50 1.4×	10	257
Paul Gonzales United States	7	100 1.0×	219 2.5×	25 0.4×	36 0.7×	13 0.4×	19	360
Iris Leung Canada	5	98 1.0×	97 1.1×	40 0.6×	17 0.3×	38 1.0×	5	229

Countries citing papers authored by Minwei Ye

Since Specialization

Citations

This map shows the geographic impact of Minwei Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minwei Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minwei Ye more than expected).

Fields of papers citing papers by Minwei Ye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minwei Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minwei Ye. The network helps show where Minwei Ye may publish in the future.

Co-authorship network of co-authors of Minwei Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Minwei Ye. A scholar is included among the top collaborators of Minwei Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minwei Ye. Minwei Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Mele, Deanna A., Neil P. Grimster, Gayathri Bommakanti, et al.. (2023). Abstract 3453: First disclosure of a highly potent and selective HPK1 inhibitor that rescues T cell exhaustion. Cancer Research. 83(7_Supplement). 3453–3453. 3 indexed citations

Li, Shi, Jinhui Xu, & Minwei Ye. (2020). Approximating Global Optimum for Probabilistic Truth Discovery. Algorithmica. 82(10). 3091–3116. 2 indexed citations

Chandra, Dinesh, Christine M. Barbon, Alexandra Borodovsky, et al.. (2020). Abstract A87: The A2AR antagonist AZD4635 prevents adenosine-mediated immunosuppression in tumor microenvironment and enhances antitumor immunity partly by enhancing CD103+ dendritic cells. Cancer Immunology Research. 8(3_Supplement). A87–A87. 2 indexed citations

Borodovsky, Alexandra, Yanjun Wang, Minwei Ye, et al.. (2018). Abstract 3751: Inhibition of A2AR by AZD4635 induces anti-tumor immunity alone and in combination with anti-PD-L1 in preclinical models. Cancer Research. 78(13_Supplement). 3751–3751. 8 indexed citations

Borodovsky, Alexandra, Yanjun Wang, Minwei Ye, et al.. (2017). Abstract 5580: Preclinical pharmacodynamics and antitumor activity of AZD4635, a novel adenosine 2A receptor inhibitor that reverses adenosine mediated T cell suppression. Cancer Research. 77(13_Supplement). 5580–5580. 19 indexed citations

Lamb, Michelle L., Bo Peng, Jon Read, et al.. (2013). Discovery of novel Jak2–Stat pathway inhibitors with extended residence time on target. Bioorganic & Medicinal Chemistry Letters. 23(10). 3105–3110. 17 indexed citations

Woessner, Richard, Geraldine Bebernitz, Kirsten Bell, et al.. (2013). Abstract 931: Highly selective JAK1 kinase inhibitors suppress Y705-mediated STAT3 activation in a wide range of tumor types, with reduced hematological toxicity.. Cancer Research. 73(8_Supplement). 931–931.

Su, Qibin, Stephanos Ioannidis, Claudio Chuaqui, et al.. (2013). Discovery of 1-Methyl-1H-imidazole Derivatives as Potent Jak2 Inhibitors. Journal of Medicinal Chemistry. 57(1). 144–158. 52 indexed citations

Ioannidis, Stephanos, Michelle L. Lamb, Audrey M. Davies, et al.. (2009). Discovery of pyrazol-3-ylamino pyrazines as novel JAK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(23). 6524–6528. 21 indexed citations

10.

Scott, David A., Brian Aquila, Geraldine Bebernitz, et al.. (2008). Pyridyl and thiazolyl bisamide CSF-1R inhibitors for the treatment of cancer. Bioorganic & Medicinal Chemistry Letters. 18(17). 4794–4797. 14 indexed citations

11.

Gozgit, Joseph M., Geraldine Bebernitz, Minwei Ye, et al.. (2008). Effects of the JAK2 Inhibitor, AZ960, on Pim/BAD/BCL-xL Survival Signaling in the Human JAK2 V617F Cell Line SET-2. Journal of Biological Chemistry. 283(47). 32334–32343. 77 indexed citations

12.

Gozgit, Joseph M., Geraldine Bebernitz, Minwei Ye, et al.. (2007). Effects of a Novel, Selective Jak2 Inhibitor, AZ60, on STAT5 Signaling and Cellular Growth in Jak2 V617F Cell Lines.. Blood. 110(11). 3549–3549. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact